Post-stroke medication adherence and persistence rates: a meta-analysis of observational studies
- 49 Downloads
Following a doctor’s prescribed medication regimen is the key to prevent recurrent stroke and adverse outcomes. Many studies have investigated post-stroke drug adherence and persistence in patients. However, a comprehensive analysis of the data is lacking.
A meta-analysis of published literature was conducted to summarize the ratio of medication adherence and persistence in patients after stroke.
Relevant studies were identified by conducting a literature search using PubMed, EMBASE and Web of Science up to April 2019. We also reviewed the reference list of the retrieved articles to identify additional studies. We included observational studies that reported data on patients’ medication adherence or persistence status, or the rate of medication adherence or persistence among patients with stroke could be calculated based on the information provided.
The overall high medication adherence rate of patients with stroke was 64.1% (95% CI: 57.4%–70.8%), and the persistence rate of patients with stroke was 72.2% (95% CI: 69.1%–75.3%). The highest persistence rate was observed in cohort studies which was 80.1% (95% CI: 76.7%–83.4%). The medication adherence rate was the highest in cases where the rates were assessed through interviews or self-reports (77.7% (95% CI: 71.3%–84.1%)).
Medication adherence and persistence rates are low in patients after suffering a stroke. Patient medication adherence or persistence and their influencing factors should be considered for the treatment of stroke patients. More detailed disease prevention and management strategies need to be developed for stroke patients with different comorbidities.
KeywordsPost-stroke Stroke patients Medication adherence Medication persistence
JZ and XY conceived the study. JZ and YG conducted the literature search. YG identified potentially relevant research based on the title and abstract of the article. JZ and YZ reviewed these potential studies and determined the final included studies according to the inclusion and exclusion criteria. JZ and YG extracted data from the included studies and assessed the quality of the studies. NJ and JW checked the extracted data. JZ and YG analyzed the data and prepared the draft of the manuscript. XY and YG criticized and revised the manuscript. All authors reviewed the study findings and read and approved the final manuscript. XY is the guarantor of this study.
This study was a part of our routine work.
Compliance with ethical standards
Conflicts of interest
There were no conflicts of interest to declare.
- 1.James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N et al (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1789–1858CrossRefGoogle Scholar
- 2.Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N et al (2018) Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1859–1922CrossRefGoogle Scholar
- 3.Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva, World Health Organization;2018. https://www.who.int/healthinfo/global_burden_disease/estimates/en/.
- 18.Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD et al (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45(7):2160–2236PubMedPubMedCentralCrossRefGoogle Scholar
- 21.Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K et al (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 113(10):e409–e449PubMedCrossRefPubMedCentralGoogle Scholar
- 27.Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama. 2000;283(15):2008–12.Google Scholar
- 28.Rostom A, Dubé C, Cranney A, et al. Celiac Disease. Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 Sep. (Evidence Reports/Technology Assessments, No. 104.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK35149/.
- 29.Mathew MC, Ervin AM, Tao J, Davis RM. Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract. Cochrane Database Syst Rev 2012(6):Cd004567.Google Scholar
- 30.Zeng Y, Tang Y, Tang J, Shi J, Zhang L, Zhu T, et al. Association between the different duration of breastfeeding and attention deficit/hyperactivity disorder in children: a systematic review and meta-analysis. Nutr Neurosci 2018:1–13.Google Scholar
- 31.Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, ON: Ottawa Health Research Institute, 2009 https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
- 49.Dahlgren C, Geary L, Hasselstrom J, Rehnberg C, Schenck-Gustafsson K, Wandell P et al (2017) Recording a diagnosis of stroke, transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication: a registry-based prospective cohort study. BMJ Open 7(9):e015723PubMedPubMedCentralCrossRefGoogle Scholar